Orthocell’s record $17 million capital raise has been featured in The West Australian newspaper in an article titled “Orthocell confirms record $17 million raising to launch in the US” by journalist Sean Smith.
The article highlights the progress the Company has made as it advances plans to enter the US market with nerve repair product Remplir.
An excerpt:
“The stock has nearly doubled in value since September on a series of positive regulatory and operational updates.”
Click here to read the article.